An American College of Rheumatology/European League Against Rheumatism Collaborative Initiative

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Study for Updated Gout Classification Criteria: Identification of Features to Classify Gout

  2015cited by this paper
• Distinctions Between Diagnostic and Classification Criteria?

  2015cited by this paper
• Identification of patients with gout: elaboration of a questionnaire for epidemiological studies

  2014cited by this paper
• Imaging modalities for the classification of gout: systematic literature review and meta-analysis

  2014cited by this paper
• Rising burden of gout in the UK but continuing suboptimal management: a nationwide population study

  2014cited by this paper
• SAT0544 Prevalence of Gout in the Adult Population of France in 2013

  2014cited by this paper
• Artifacts in dual-energy CT gout protocol: a review of 50 suspected cases with an artifact identification guide.

  2014cited by this paper
• Multicriteria decision analysis methods with 1000Minds for developing systemic sclerosis classification criteria.

  2014cited by this paper
• AB0629 A critical appraisal of the competence of crystal identification by rheumatologists.

  2013cited by this paper
• New classification criteria for gout: a framework for progress.

  2013cited by this paper
• 2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative

  2013cited by this paper
• A Delphi Exercise to Identify Characteristic Features of Gout — Opinions from Patients and Physicians, the First Stage in Developing New Classification Criteria

  2013cited by this paper
• Primary care providers' knowledge, beliefs and treatment practices for gout: results of a physician questionnaire.

  2013cited by this paper
• Ultrasound-detected musculoskeletal urate crystal deposition: which joints and what findings should be assessed for diagnosing gout?

  2013cited by this paper
• Items for developing revised classification criteria in systemic sclerosis: Results of a consensus exercise

  2012cited by this paper
• Gout, diabetes and cardiovascular disease in the Aotearoa New Zealand adult population: co-prevalence and implications for clinical practice.

  2012influential reference
• Validation of potential classification criteria for systemic sclerosis

  2012cited by this paper
• Tips and tricks to recognize microcrystalline arthritis.

  2012cited by this paper
• Diagnosis and Classification of Systemic Sclerosis

  2011cited by this paper
• Identification of intraarticular and periarticular uric acid crystals with dual-energy CT: initial evaluation.

  2011influential reference
• Prevalence of gout and hyperuricemia in the US general population: the National Health and Nutrition Examination Survey 2007-2008.

  2011cited by this paper
• A diagnostic rule for acute gouty arthritis in primary care without joint fluid analysis.

  2010cited by this paper
• The 2010 American College of Rheumatology/European League Against Rheumatism classification criteria for rheumatoid arthritis: Phase 2 methodological report.

  2010cited by this paper
• Preliminary criteria for the very early diagnosis of systemic sclerosis: results of a Delphi Consensus Study from EULAR Scleroderma Trials and Research Group

  2010cited by this paper
• Diagnosis of Chronic Gout: Evaluating the American College of Rheumatology Proposal, European League Against Rheumatism Recommendations, and Clinical Judgment

  2010cited by this paper
• Reliability of widefield capillary microscopy to measure nailfold capillary density in systemic sclerosis.

  2010cited by this paper
• 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative.

  2010cited by this paper
• Clinical Diagnostic Criteria for Gout: Comparsion With the Gold Standard of Synovial Fluid Crystal Analysis

  2009cited by this paper
• Autoantibodies and microvascular damage are independent predictive factors for the progression of Raynaud's phenomenon to systemic sclerosis: a twenty-year prospective study of 586 patients, with validation of proposed criteria for early systemic sclerosis.

  2008influential reference
• A new method for scoring additive multi‐attribute value models using pairwise rankings of alternatives

  2008cited by this paper
• Classification criteria in rheumatic diseases: a review of methodologic properties.

  2007cited by this paper
• The development of systemic sclerosis classification criteria

  2007cited by this paper
• Classification criteria for rheumatic diseases: why and how?

  2007cited by this paper
• Gout in the UK and Germany: prevalence, comorbidities and management in general practice 2000–2005

  2007cited by this paper
• Office capillaroscopy in systemic sclerosis

  2007cited by this paper
• Improving the sensitivity of the American College of Rheumatology classification criteria for systemic sclerosis.

  2007cited by this paper
• Nailfold capillaroscopy and classification criteria for systemic sclerosis.

  2007cited by this paper
• Development of classification and response criteria for rheumatic diseases.

  2006cited by this paper
• Classification of systemic sclerosis. Visions and reality.

  2005influential reference
• Gout epidemiology: results from the UK General Practice Research Database, 1990–1999

  2005cited by this paper
• A proposal of criteria for the classification of systemic sclerosis.

  2004cited by this paper
• Updating the American College of Rheumatology preliminary classification criteria for systemic sclerosis: addition of severe nailfold capillaroscopy abnormalities markedly increases the sensitivity for limited scleroderma.

  2001influential reference
• Criteria for the classification of early systemic sclerosis.

  2001influential reference
• How is Gout Managed in Primary Care? A Review of Current Practice and Proposed Guidelines

  2000cited by this paper
• Autoantibodies in systemic sclerosis.

  1996cited by this paper
• Methodological and statistical approaches to criteria development in rheumatic diseases.

  1995cited by this paper
• Scleroderma (systemic sclerosis): classification, subsets and pathogenesis.

  1988cited by this paper
• A prospective study of Raynaud phenomenon and early connective tissue disease. A five-year report.

  1982cited by this paper
• Early detection of scleroderma-spectrum disorders by in vivo capillary microscopy: a prospective study of patients with Raynaud's phenomenon.

  1982cited by this paper
• The 1982 revised criteria for the classification of systemic lupus erythematosus.

  1982cited by this paper
• Preliminary criteria for the classification of systemic sclerosis (scleroderma).

  1980cited by this paper
• Methods and preliminary results of the scleroderma criteria cooperative study of the American Rheumatism Association

  1979cited by this paper
• Preliminary criteria for the classification of the acute arthritis of primary gout.

  1977cited by this paper
• The Epidemiology of Chronic Rheumatism

  1964cited by this paper

• Decoding lysophosphatidic acid signaling in physiology and disease: mapping the multimodal and multinodal signaling networks

  2025cites this paper
• Cystatin D as a biomarker for rheumatoid arthritis: relation to disease activity and joint damage

  2025cites this paper
• T Cells Enhance Tissue Complexity and Function to Study Fibrosis in 3D Skin-Like Tissue Models

  2025cites this paper
• Critical Role for Transglutaminase 2 in Scleroderma Skin Fibrosis and in the Development of Dermal Sclerosis in a Mouse Model of Scleroderma

  2025cites this paper
• Classification of capillary damage in patients with type 2 diabetes mellitus: Clinical parameters obtained through capillaroscopy—A cross-sectional study

  2025cites this paper
• Diagnostic challenges of spinal gout: patient series

  2025cites this paper
• Diffuse Cutaneous Systemic Sclerosis With Normotensive Scleroderma Renal Crisis and Myopericarditis: A Case Report

  2025cites this paper
• Serum Calprotectin as a Novel Biomarker of Disease Severity and Activity in Systemic Sclerosis Patients

  2025cites this paper
• Radiographic Bone Texture Analysis using Deep Learning Models for Early Rheumatoid Arthritis Diagnosis.

  2025cites this paper
• Higher serotonin levels among patients with rheumatoid arthritis, psoriatic arthritis, and axial spondyloarthritis compared to healthy controls assessed by liquid chromatography–tandem mass spectrometry (LC-MS)

  2025cites this paper
• Exhaled Nitric Oxide Reflects the Immune Reactions of the Airways in Early Rheumatoid Arthritis

  2024cites this paper
• PSGL-1, ADAM8, and selectins as potential biomarkers in the diagnostic process of systemic lupus erythematosus and systemic sclerosis: an observational study

  2024influential citation
• Association of serum uric acid with right cardiac chamber remodeling assessed by cardiovascular magnetic resonance feature tracking in patients with connective tissue disease

  2024influential citation
• Medical Ozone: A Redox Regulator with Selectivity for Rheumatoid Arthritis Patients

  2024cites this paper
• Seasonal and Treatment-Related Variation in 25-Hydroxy Vitamin D Concentration in Patients with Rheumatoid Arthritis

  2024cites this paper
• High Prevalence of the Lung Ultrasound Interstitial Syndrome in Systemic Sclerosis Patients with Normal HRCT and Lung Function—A Pilot Study

  2024cites this paper
• Scleroderma and scleroderma-like syndromes

  2024cites this paper
• Beneficial effect of temporary methotrexate interruption on B and T cell responses upon SARS-CoV-2 vaccination in patients with rheumatoid arthritis or psoriatic arthritis

  2024cites this paper
• Is Active Synovitis of Metacarpophalangeal Joints a Neuropathic Condition in Rheumatoid Arthritis Patients? Results from an Ultrasound Study of Palmar Digital Nerves

  2024cites this paper
• Clinical Phenotypes, Serological Biomarkers, and Synovial Features Defining Seropositive and Seronegative Rheumatoid Arthritis: A Literature Review

  2024cites this paper
• Neural network analysis as a novel skin outcome in a trial of belumosudil in patients with systemic sclerosis

  2024cites this paper
• Real-Life Comparison of Four JAK Inhibitors in Rheumatoid Arthritis (ELECTRA-i Study)

  2024cites this paper
• Differential effect of lactate on synovial fibroblast and macrophage effector functions

  2023cites this paper
• Manifestations cliniques cutanéo-muqueuses et auto-immunité

  2023cites this paper
• Nailfold capillaroscopy and candidate-biomarker levels in systemic sclerosis-associated pulmonary hypertension: A cross-sectional study

  2023cites this paper
• Clinical Characterization and Predictive Factors for Progression in a Cohort of Patients with Interstitial Lung Disease and Features of Autoimmunity: The Need for a Revision of IPAF Classification Criteria

  2023cites this paper
• Predictors and survival of cardiomyopathy determined by echocardiography in Thai patients with early systemic sclerosis: an inception cohort study

  2023cites this paper
• Serum metabolomic profiling reveals potential biomarkers in systemic sclerosis.

  2023cites this paper
• Clinical Risk Factors for Dysphagia and Esophageal Dysmotility in Systemic Sclerosis

  2023influential citation
• Assessment of Intestinal Permeability and Inflammation Bio-Markers in Patients with Rheumatoid Arthritis

  2023cites this paper
• The Rise and Rise of Lupus

  2023cites this paper
• Multiparametric Skin Assessment in a Monocentric Cohort of Systemic Sclerosis Patients: Is There a Role for Ultra-High Frequency Ultrasound?

  2023cites this paper
• Patient Experience of Systemic Sclerosis-Related Calcinosis: An International Study Informing Clinical Trials, Practice, and the Development of the Mawdsley Calcinosis Questionnaire.

  2023cites this paper
• A comparative study of modulatory interaction between cytokines and apoptotic proteins among Scleroderma patients with and without pulmonary involvement.

  2023cites this paper
• Training the Next Generation of Rheumatologists: What Is the Best Way to Teach Fellows About Scleroderma?

  2023cites this paper
• Microparticles: potential new contributors to the pathogenesis of systemic sclerosis?

  2023cites this paper
• The nailfold dermoscopy findings of patients with atypical haemolytic uremic syndrome.

  2023cites this paper
• Is oropharyngoesophageal scintigraphy the method of choice for assessing dysphagia in systemic sclerosis? A single center experience

  2023cites this paper
• The Role of Lung Ultrasound in Systemic Sclerosis

  2023cites this paper
• Qualitative analysis of nailfold capillaries in diabetes and diabetic retinopathy using dermatoscope in patients with coloured skin.

  2023cites this paper
• Real-life efficacy and safety of nintedanib in systemic sclerosis-interstitial lung disease: data from an Italian multicentre study

  2023cites this paper
• Low Gut Microbial Diversity Augments Estrogen-Driven Pulmonary Fibrosis in Female-Predominant Interstitial Lung Disease

  2023cites this paper
• Rapid Biomarker-Based Diagnosis of Fibromyalgia Syndrome and Related Rheumatologic Disorders by Portable FT-IR Spectroscopic Techniques

  2023cites this paper
• Cardiovascular disease risk prediction in scleroderma

  2023cites this paper
• The Lübeck Medication Satisfaction Questionnaire—A Novel Measurement Tool for Therapy Satisfaction

  2023cites this paper
• Elevation of serum tenascin‐C levels in dermatomyositis patients

  2023cites this paper
• Microvascular damage evaluation based on nailfold videocapillarosopy in sarcoidosis

  2023cites this paper
• An Evidence-Based Update on the Potential Association between Rheumatoid Arthritis and Lymphangioleiomyomatosis

  2023cites this paper
• Step forward in early recognition of systemic sclerosis: data from the Leiden CCISS cohort

  2023cites this paper
• Scleroderma Skin: How Is Treatment Best Guided by Data and Implemented in Clinical Practice?

  2023cites this paper
• Cardiac magnetic resonance imaging T1 mapping and late gadolinium enhancement entropy: Prognostic value in patients with systemic sclerosis.

  2023cites this paper
• Serum kynurenic acid is lower in systemic sclerosis patients with microvascular damage of hands.

  2023cites this paper
• Application and performance of disease activity indices proposed for patients with systemic sclerosis in an international cohort of patients with juvenile systemic sclerosis

  2023cites this paper
• Caspase 1 Enhances Transport and Golgi Organization Protein 1 Expression to Promote Procollagen Export From the Endoplasmic Reticulum in Systemic Sclerosis Contributing to Fibrosis

  2023cites this paper
• Salivary Antioxidant Profile in Patients with Systemic Sclerosis and Periodontitis

  2023cites this paper
• Efficacy and Safety of Lenabasum, a Cannabinoid Type 2 Receptor Agonist, in a Phase 3 Randomized Trial in Diffuse Cutaneous Systemic Sclerosis

  2023cites this paper
• Audiovestibular Manifestations in Patients with Primary Raynaud’s Phenomenon and Raynaud’s Phenomenon Secondary to Systemic Sclerosis

  2023cites this paper
• High frequency ultrasound assessment of skin in systemic sclerosis patients

  2023cites this paper
• The association between CONUT score, mRSS, and development of digital ulcers in SSc patients

  2023cites this paper
• Systemic Sclerosis Quality of Life Questionnaire (SScQoL): translation into Turkish and assessing its psychometric properties

  2023cites this paper
• Incidence and Predictors of an Abnormal Liver Function Test Among 674 Systemic Sclerosis Patients: A Cohort Study

  2023cites this paper
• Liver Involvement in Patients with Systemic Sclerosis: Role of Transient Elastography in the Assessment of Hepatic Fibrosis and Steatosis

  2023cites this paper
• Alleviation of arthritis through prevention of neutrophil extracellular traps by an orally available inhibitor of protein arginine deiminase 4

  2023cites this paper
• Long-term Outcomes After Rituximab Treatment for Patients With Systemic Sclerosis: Follow-up of the DESIRES Trial With a Focus on Serum Immunoglobulin Levels.

  2023cites this paper
• A 24‐Week, Phase IIa, Randomized, Double‐Blind, Placebo‐Controlled Study of Ziritaxestat in Early Diffuse Cutaneous Systemic Sclerosis

  2023cites this paper
• Care patterns and Traditional Chinese Medicine constitution as factors of depression and anxiety in patients with systemic sclerosis: A cross-sectional study during the COVID-19 pandemic

  2023cites this paper
• Citrullination modulates antigen processing and presentation by revealing cryptic epitopes in rheumatoid arthritis

  2023cites this paper
• Evaluation of Measurement Properties and Differential Item Functioning in the English and French Versions of the University of California, Los Angeles, Loneliness Scale‐6: A Scleroderma Patient‐Centered Intervention Network (SPIN) Study

  2023cites this paper
• Myositis autoantibodies detected by line blot immunoassay: clinical associations and correlation with antibody signal intensity

  2023cites this paper
• Progression from suspected to definite systemic sclerosis and the role of anti-topoisomerase I antibodies

  2023cites this paper
• Listing Dilemmas: Age, Frailty, Weight, Preexisting Cancers, and Systemic Diseases.

  2023cites this paper
• Anti-acid therapy in SSc-associated interstitial lung disease: long-term outcomes from the German Network for Systemic Sclerosis

  2023cites this paper
• UVA1 irradiation attenuates collagen production via Ficz/AhR/MAPK signaling activation in scleroderma.

  2023cites this paper
• Systemic Sclerosis Patients Experiencing Mindfulness-Based Stress Reduction Program: The Beneficial Effect on Their Psychological Status and Quality of Life

  2023cites this paper
• Scleromyositis: A distinct novel entity within the systemic sclerosis and autoimmune myositis spectrum. Implications for care and pathogenesis

  2023influential citation
• Anti-RuvBL1/2 Autoantibodies Detection in a Patient with Overlap Systemic Sclerosis and Polymyositis

  2023cites this paper
• Quality Measures in Systemic Sclerosis

  2023cites this paper
• Interferon and interferon-induced cytokines as markers of impending clinical progression in ANA+ individuals without a systemic autoimmune rheumatic disease diagnosis

  2023cites this paper
• Peripheral Macrovascular Involvement in Systemic Sclerosis: A Cohort Study by Color and Spectral Doppler Ultrasonography

  2023cites this paper
• Serum Immunoglobulin G (IgG) Subclasses in a Cohort of Systemic Sclerosis Patients

  2023cites this paper
• Systemic Lupus Erythematosus May Be a Risk Factor for Antimalarial‐Induced Retinopathy Compared With Other Rheumatologic Diseases

  2023cites this paper
• Ultrasound quantitative assessment of ventral finger microvasculopathy in systemic sclerosis with Raynaud’s phenomena: a comparative study

  2023cites this paper
• Relationship of systemic type I interferon activity with clinical phenotypes, disease activity, and damage accrual in systemic lupus erythematosus in treatment-naive patients: a retrospective longitudinal analysis

  2023cites this paper
• Global, regional, and national incidence and prevalence of systemic sclerosis.

  2023cites this paper
• Development of Autoantibodies Following BNT162b2 mRNA COVID-19 Vaccination and Their Association with Disease Flares in Adult Patients with Autoimmune Inflammatory Rheumatic Diseases (AIIRD) and the General Population: Results of 1-Year Prospective Follow-Up Study

  2023cites this paper
• Oral mucosal breaks trigger anti-citrullinated bacterial and human protein antibody responses in rheumatoid arthritis

  2023cites this paper
• The Function of Retinal Thickness and Microvascular Alterations in the Diagnosis of Systemic Sclerosis

  2023cites this paper
• Advanced Autoantibody Testing in Systemic Sclerosis

  2023cites this paper
• Approach to Systemic Sclerosis Patient Assessment: How Does Patient Subsetting Help?

  2023cites this paper
• Systemic sclerosis sine scleroderma: clinical and serological features and relationship with other cutaneous subsets in a large series of patients from the national registry ‘SPRING’ of the Italian Society for Rheumatology

  2023cites this paper
• Nailfold capillaroscopy.

  2023cites this paper
• Differentially expressed genes in systemic sclerosis: Towards predictive medicine with new molecular tools for clinicians.

  2023cites this paper
• Native T1 mapping in early diffuse and limited systemic sclerosis, and its association with diastolic function.

  2023cites this paper
• Anti‐DFS70 antibodies are associated with atopic dermatitis and can cause misdiagnosis of connective tissue disease

  2023cites this paper
• Optical spectral transmission to assess glucocorticoid therapy response in patients with arthritis: a longitudinal follow-up comparison with joint ultrasound

  2023cites this paper
• Clinical significance of anti-DFS70 in immunoinflammatory rheumatic diseases (review)

  2023cites this paper
• Circulating miRNA-19b as a biomarker of disease progression and treatment response to baricitinib in rheumatoid arthritis patients through miRNA profiling of monocytes

  2023cites this paper
• Anti-U11/U12 Antibodies as a Rare but Important Biomarker in Patients with Systemic Sclerosis: A Narrative Review

  2023cites this paper
• Pneumoconiosis combined with connective tissue disease in China: a cross-sectional study

  2023cites this paper
• Clinical significance of anti-rheumatoid arthritis 33 antibody in patients with systemic lupus erythematosus

  2023cites this paper